✦ LIBER ✦

603 POSTER Effect of the SRC tyrosine kinase inhibitor dasatinib in combination with erlotinib and in cells with acquired resistance to erlotinib

✍ Scribed by E. Haura; J. Gao; J. Li

Book ID: 118624231
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 56 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70608-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease Flare after Tyrosine Kinase Inhi

Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

✍ Chaft, J. E.; Oxnard, G. R.; Sima, C. S.; Kris, M. G.; Miller, V. A.; Riely, G. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 338 KB

1127 POSTER Phase II study of the EGFR t

1127 POSTER Phase II study of the EGFR tyrosine kinase inhibitor erlotinib in patients >70 years of age with previously untreated advanced non-small cell lung carcinoma

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Phase I, pharmacokinetic (PK), and biolo

Phase I, pharmacokinetic (PK), and biological studies of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitor OSI-774 (Erlotinib or Tarceva) in combination with docetaxel

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

9118 POSTER Prospective Assesment of Com

9118 POSTER Prospective Assesment of Combined Pemetrexed and Erlotinib or Gefitinib Therapy After the Relapse to Erlotinib or Gefitinib in Patients With Advanced Non-Small Cell Lung Cancer Having an Active Epidermal Growth Factor Receptor Mutation

✍ Okishio, K.; Yoshimura, N.; Kimura, T.; Daga, H.; Takeda, K.; Kawaguchi, T.; Kob 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

6632 Characterisation of the response of

6632 Characterisation of the response of pancreatic cancer cells to treatment with chemotherapeutic agents alone and in combination with tyrosine kinase inhibitors

✍ Sheikh, R.; O'connor, R.; Walsh, N.; Clynes, M.; Mcdermott, R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The effect of ZD1839 (IressaTM), an epid

The effect of ZD1839 (IressaTM), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells

✍ A. Al-Hazzaa; I. D. Bowen; P. Randerson; M. A. Birchall 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB